Macrophages in gene therapy: Cellular delivery vehicles and in vivo targets

Journal of Leukocyte Biology

Volumn 72, Issue 3, 2002, Pages 417-428

  Burke, B ^a   Sumner, S ^b   Maitland, N ^c   Lewis, C E ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Doptive immunotherapy; Homing; Transcriptional targeting; Transfection; Vector

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 1 ANTITRYPSIN; BETA GLUCURONIDASE; CD14 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NAKED DNA; PLASMID DNA; RETROVIRUS VECTOR; RIBOZYME; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL MODEL; ATHEROSCLEROSIS; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; LIVER DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG FIBROSIS; LYSOSOME STORAGE DISEASE; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; POXVIRUS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SILICOSIS; TUMOR IMMUNOLOGY; VIRAL GENE THERAPY; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; ARTHRITIS; CELL MOVEMENT; CYTOKINES; DNA; GENE THERAPY; GENETIC VECTORS; GROWTH SUBSTANCES; HIV INFECTIONS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEISHMANIA; LISTERIA; LYSOSOMAL STORAGE DISEASES; MACROPHAGES; MICE; NEOPLASMS; RATS; RETROVIRIDAE; SALMONELLA; TRANSFECTION; TRANSFORMATION, GENETIC;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); POXVIRIDAE; PROTOZOA; UNIDENTIFIED RETROVIRUS;

EID: 0036744016     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Ross, J. A., Auger, M. J. (2002) The biology of the macrophage. In The Macrophage, 2nd ed. (B. Burke, C. E. Lewis, eds.), Oxford University Press, Oxford, UK, in press.
2. Nagata, Y., Diamond, B., Bloom, B. R. (1983) The generation of human monocyte/macrophage cell lines. Nature 306, 597-599.
3. Mountain, A. (2000) Gene therapy: the first decade. Trends Biotechnol. 18, 119-128.
4. Haddada, H., Lopez, M., Martinache, C., Ragot, T., Abina, M. A., Perricaudet, M. (1993) Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 195, 1174-1183.
5. Schneider, S. D., Rusconi, S., Seger, R. A., Hossle, J. P. (1997) Adeno-virus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst. Gene Ther. 4, 524-532.
6. De, S. K., Venkateshan, C. N., Seth, P., Gajdusek, D. C., Gibbs, C. J. (1998) Adenovirus-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on down-modulation of Fcgamma receptors and expression of monokines. Blood 91, 2108-2117.
7. Heider, H., Verca, S. B., Rusconi, S., Asmis, R. (2000) Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells. Biotechniques 28, 260-265, 268-270.
8. Wirtz, S., Becker, C., Blumberg, R., Galle, P. R., Neurath, M. F. (2002) Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 168, 411-420.
9. Foxwell, B., Browne, K., Bondeson, J., Clarke, C., de Martin, R., Brennan, F., Feldmann, M. (1998) Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. Proc. Natl. Acad. Sci. USA 95, 8211-8215.
10. Parveen, Z., Krupetsky, A., Engelstadter, M., Cichutek, K., Pomerantz, R. J., Dornburg, R. (2000) Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells. Nat. Biotechnol. 18, 623-629.
11. Vassilopoulos, G., Trobridge, G., Josephson, N. C., Russell, D. W. (2001) Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 98, 604-609.
12. Chischportich, C., Bagnis, C., Galindo, R., Mannoni, P. (1999) Expression of the nlsLacz gene in dendritic cells derived from retrovirally transduced peripheral blood CD34+ cells. Haematologica 84, 195-203.
13. Miyake, K., Suzuki, N., Matsuoka, H., Tohyama, T., Shimada, T. (1998) Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells. Hum. Gene Ther. 9, 467-475.
14. Schroers, R., Sinha, I., Segall, H., Schmidt-Wolf, I. G., Rooney, C., Brenner, M. K., Sutton, R. E., Chen, S. Y. (2000) Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol. Ther. 1, 171-179.
15. Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M., Naldini, L. (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25, 217-222.
16. Schuitemaker, H., Miedema, F. (1992) Viral and cellular determinants of HIV-1 replication in macrophages. AIDS 10 (Suppl. A), S25-S32.
17. Schuitemaker, H., Kootstra, N. A., Fouchier, R. A., Hooibrink, B., Miedema, F. (1994) Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity. EMBO J. 13, 5929-5936.
18. Wu, X., Wakefield, J. K., Liu, H., Xiao, H., Kralovics, R., Prchal, J. T., Kappes, J. C. (2000) Development of a novel trans-lentiviral vector that affords predictable safety. Mol. Ther. 2, 47-55.
19. Liu, Y., Santin, A. D., Mane, M., Chiriva-Internati, M., Parham, G. P., Ravaggi, A., Hermonat, P. L. (2000) Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus. J. Interferon Cytokine Res. 20, 21-30.
20. Ponnazhagan, S., Mahendra, G., Curiel, D. T., Shaw, D. R. (2001) Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy. J. Virol. 75, 9493-9501.
21. Paul, S., Bizouarne, N., Dott, K., Ruet, L., Dufour, P., Acres, R. B., Kieny, M. P. (2000) Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody. Cancer Gene Ther. 7, 615-623.
22. Paul, S., Snary, D., Hoebeke, J., Allen, D., Balloul, J. M., Bizouarne, N., Dott, K., Geist, M., Hilgers, J., Kieny, M. P., Burchell, J., Taylor-Papa-dimitriou, J., Acres, R. B. (2000) Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment. Hum. Gene Ther.11, 1417-1428.
23. Paludan, S. R. (2001) Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J. Virol. 75, 8008-8015.
24. Nettelbeck, D. M., Miller, D. W., Jerome, V., Zuzarte, M., Watkins, S. J., Hawkins, R. E., Muller, R., Kontermann, R. E. (2001) Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105). Mol. Ther. 3, 882-891.
25. Krasnykh, V., Belousova, N., Korokhov, N., Mikheeva, G., Curiel, D. T. (2001) Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J. Virol. 75, 4176-4183.
26. Krasnykh, V. N., Douglas, J. T., van Beusechem, V. W. (2000) Genetic targeting of adenoviral vectors. Mol. Ther. 1, 391-405.
27. Bennet, R. M., Gabor, G. T., Merrit, M. (1985) DNA binding to human leucocytes: evidence for a receptor-mediated association, internalization and degradation of DNA. J. Clin. Investig. 76, 2182-2190.
28. Stacey, K. J., Sweet, M. J., Hume, D. A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116-2122.
29. Meuli, M., Liu, Y., Liggitt, D., Kashani-Sabet, M., Knauer, S., Meuli-Simmen, C., Harrison, M. R., Adzick, N. S., Heath, T. D., Debs, R. J. (2001) Efficient gene expression in skin wound sites following local plasmid injection. J. Investig. Dermatol. 116, 131-135.
30. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., Falo Jr., L. D. (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2, 1122-1128.
31. Stacey, K. J., Sester, D. P., Sweet, M. J., Hume, D. A. (2000) Macrophage activation by immunostimulatory DNA. Curr. Top. Microbiol. Immunol. 247, 41-58.
32. Krieg, A. M. J. (1999) Direct immunologic activities of CpG DNA and implications for gene therapy. J. Gene Med. 1, 56-63.
33. Weir, J. P., Meltzer, M. S. (1993) Transfection of human immunodeficiency virus type 1 proviral DNA into primary human monocytes. Cell. Immunol. 148, 157-165.
34. Takahashi, M., Furukawa, T., Tanaka, I., Nikkuni, K., Aoki, A., Kishi, K., Koike, T., Moriyama, Y., Shibata, A. (1992) Gene introduction into granulocyte-macrophage progenitor cells by electroporation: the relationship between introduction efficiency and the proportion of cells in S-phase. Leuk. Res. 16. 761-767.
35. Liao, H. S., Kodama, T., Doi, T., Emi, M., Asaoka, H., Itakura, H., Matsumoto, A. (1997) Novel elements located at -504 to -399 bp of the promoter region regulated the expression of the human macrophage scavenger receptor gene in murine macrophages. J. Lipid Res. 38, 1433-1444.
36. Kusumawati, A., Commes, T., Liautard, J. P., Widada, J. S. (1999) Transfection of myelomonocytic cell lines: cellular response to a lipid-based reagent and electroporation. Anal. Biochem. 269, 219-221.
37. Li, L. H., McCarthy, P., Hui, S. W. (2001) High-efficiency electrotransfection of human primary hematopoietic stem cells. FASEB J. 15, 586-588.
38. Mack, K. D., Wei, R., Elbagarri, A., Abbey, N., McGrath, M. S. (1998) A novel method for DEAE-dextran mediated transfection of adherent primary cultured human macrophages. J. Immunol. Methods 211, 79-86.
39. Dokka, S., Toledo, D., Shi, X., Ye, J., Rojanasakul, Y. (2000) High-efficiency gene transfection of macrophages by lipoplexes. Int. J. Pharm. 206, 97-104.
40. Liu, Y., Mounkes, L. C., Liggitt, H. D., Brown, C. S., Solodin, I., Heath, T. D., Debs, R. J. (1997) Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. 15, 167-173.
41. McLean, J. W., Fox, E. A., Baluk, P., Bolton, P. B., Haskell, A., Pearlman, R., Thurston, G., Umemoto, E. Y., McDonald, D. M. (1997) Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 273, H387-H404.
42. Duzgunes, N., Pretzer, E., Simoes, S., Slepushkin, V., Konopka, K., Flasher, D., de Lima, M. C. (1999) Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells. Mol. Membr. Biol. 16, 111-118.
43. Kisich, K. O., Malone, R. W., Feldsteinm P. A., Erickson, K. L. (1999) Specific inhibition of macrophage TNF-alpha expression by in vivo ribozyme treatment. J. Immunol. 163, 2008-2016.
44. Irvine, A. S., Trinder, P. K., Laughton, D. L., Ketteringham, H., McDermott, R. H., Reid, S. C., Haines, A. M., Amir, A., Husain, R., Doshi, R., Young, L. S., Mountain, A. (2000) Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nat. Biotechnol. 18, 1273-1278.
45. Erbacher, P., Bousser, M. T., Raimond, J., Monsigny, M., Midoux, P., Roche, A. C. (1996) Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum. Gene Ther. 7, 721-729.
46. Simoes, S., Slepushkin, V., Pretzer, E., Dazin, P., Gaspar, R., Pedroso de Lima, M. C., Duzgunes, N. (1999) Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. J. Leukoc. Biol. 65, 270-279.
47. Ferkol, T., Perales, J. C., Mularo, F., Hanson, R. W. (1996) Receptor-mediated gene transfer into macrophages. Proc. Natl. Acad. Sci. USA 93, 101-105.
48. Ferkol, T., Mularo, F., Hilliard, J., Lodish, S., Perales, J. C., Ziady, A., Konstan, M. (1998) Transfer of the human alpha1-antitrypsin gene into pulmonary macrophages in vivo. Am. J. Respir. Cell Mol. Biol. 18, 591-601.
49. Kawakami, S., Sato, A., Nishikawa, M., Yamashita, F., Hashida, M. (2000) Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 7, 292-299.
50. Paglia, P., Terrazzini, N., Schulze, K., Guzman, C. A. (2000) Colombo MP. In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery. Gene Ther. 7, 1725-1730.
51. Montosi, G., Paglia, P., Garuti, C., Guzman, C. A., Bastin, J. M., Colombo, M. P., Pietrangelo, A. (2000) Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 96, 1125-1129.
52. Titus, R. G., Gueiros-Filho, F. J., de Freitas, L. A. R., Beverley, S. M. (1995) Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. USA 92, 10267-10271.
53. Vaccaro, D. E. (2000) Symbiosis therapy: the potential of using human protozoa for molecular therapy. Mol. Ther. 2, 535-538.
54. Hense, M., Domann, E., Krusch, S., Wachholz, P., Dittmar, K. E., Rohde, M., Wehland, J., Chakraborty, T., Weiss, S. (2001) Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells. Cell. Microbiol. 3, 599-609.
55. Spreng, S., Dietrich, G., Niewiesk, S., ter Meulen, V., Gentschev, I., Goebel, W. (2000) Novel bacterial systems for the delivery of recombinant protein or DNA. FEMS Immunol. Med. Microbiol. 27, 299-304.
56. Fidler, I. J. (1974) Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res. 34, 1074-1078.
57. Fidler, I. J. (1994) Therapy of cancer metastasis by systemic activation of macrophages. Adv. Pharmacol. 30, 271-326.
58. Ben-Efraim, S., Tak, C., Romijn, J. C., Fieren, M. J., Bonta, I. L. (1994) Therapeutical effect of activated human macrophages on a human tumor line growing in nude mice. Med. Oncol. 11, 7-12.
59. Andreesen, R., Hennemann, B., Krause, S. W. (1998) Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives. J. Leukoc. Biol. 64, 419-426.
60. Wiltrout, R. H., Brunda, M. J., Gorelik, E., Peterson, E. S., Dunn, J. J., Leonhardt, J., Varesio, L., Reynolds, C. W., Holden, H. T. J. (1983) Distribution of peritoneal macrophage populations after intravenous injection in mice: differential effects of eliciting and activating agents. Reticuloendothel. Soc. 34, 253-269.
61. Abreo, K., Lieberman, L. M., Moorthy, A. V. (1985) Distribution studies of 111 IN-oxine-labelled peritoneal mononuclear cells in tumor-bearing rats. Int. J. Nucl. Med. Biol. 12, 53-55.
62. Faradji, A., Bohbot, A., Frost, H., Schmitt-Goguel, M., Siffert, J. C., Dufour, P., Eber, M., Lallot, C., Wiesel, M. L., Bergerat, J. P. (1991) Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J. Clin. Oncol. 9, 1251-1260.
63. Audran, R., Collet, B., Moisan, A., Toujas, L. (1995) Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously. Nucl. Med. Biol. 22, 817-821.
64. Chokri, M., Lallot, C., Ebert, M., Poindron, P., Batholeyns, J. (1990) Biodistribution of indium-labelled macrophages in mice bearing solid tumors. Int. J. Immunol. 1, 79-84.
65. Kluth, D. C., Erwig, L. P., Pearce, W. P., Rees, A. J. (2000) Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus. Gene Ther. 7, 263-270.
66. Kluth, D. C., Ainslie, C. V., Pearce, W. P., Finlay, S., Clarke, D., Anegon, I., Rees, A. J. (2001) Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J. Immunol. 166, 4728-4736.
67. Parrish, E. P., Cifuentes-Diaz, C., Li, Z. L., Vicart, P., Paulin, D., Dreyfus, P. A., Peschanski, M., Harris, A. J., Garcia, L. (1996) Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shutdes. Gene Ther. 3, 13-20.
68. Chokri, M., Girard, A., Borrelly, M. C., Oleron, C., Romet-Lemonne, J. L., Bartholeyns, J. (1992) Adoptive immunotherapy with bispecific antibodies: targeting through macrophages. Res. Immunol. 143, 95-99.
69. Kennedy, D. W., Abkowitz, J. L. (1998) Mature monocytic cells enter tissues and engraft. Proc. Natl. Acad. Sci. USA 95, 14944-14949.
70. Vaupel, P., Kallinowski, F., Okunieff, P. (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465.
71. Griffiths, L., Binley, K., Iqball, S., Kan, O., Maxwell, P., Ratcliffe, P., Lewis, C., Harris, A., Kingsman, S., Naylor, S. (2000) The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 7, 255-262.
72. Carta, L., Pastorino, S., Melillo, G., Bosco, M. C., Massazza, S., Varesio, L. (2001) Engineering of macrophages to produce IFN-gamma in response to hypoxia. J. Immunol. 166, 5374-5380.
73. Zelzer, E., Levy, Y., Kahana, C., Shilo, B. Z., Rubinstein, M., Cohen, B. (1998) Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J. 17, 5085-5094.
74. Pastorino, S., Massazza, S., Cilli, M., Varesio, L., Bosco, M. C. (2001) Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer. Gene Ther. 8, 431-441.
75. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., Harris, A. L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56, 4625-4629.
76. Lewis, J. S., Landers, R. J., Underwood, J. C., Harris, A. L., Lewis, C. E. (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 192, 150-158.
77. Burton, J., Wells, M., Corke, K. P., Maitland, N., Hamdy, F. C., Lewis, C. E. (2000) Macrophages accumulate in avascular, hypoxic areas in prostate tumours: implications for hypoxia-targeted gene delivery to such sites. J. Pathol. 192, 8A (abstr.).
78. Bingle, L., Brown, N. J., Lewis, C. E. (2002) The role of tumor-associated macrophages in the growth and metastasis of malignant human tumors. J. Pathol. 196, 254-265.
79. Bartholeyns, J., Lopez, M. (1994) Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer. Anticancer Res. 14, 2673-2676.
80. Bartholeyns, J., Romet-Lemonne, J. L., Chokri, M., Lopez, M. (1996) Immune therapy with macrophages: present status and critical requirements for implementation. Immunobiology 195, 550-562.
81. Eto, Y., Ohashi, T. (2000) Gene therapy/cell therapy for lysosomal storage disease. J Inherit. Metab. Dis. 23, 293-298.
82. Wu, M., Hussain, S., He, Y. H., Pasula, R., Smith, P. A., Martinm W. J. (2001) Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice. Proc. Natl. Acad. Sci. USA 98, 14589-14594.
83. Speiser, D. E., Ohashi, P. S. (1998) Activation of cytotoxic T cells by solid tumours? Cell Mol. Life Sci. 54, 263-271.
84. Nishihara, K., Barth, R. F., Wilkie, N., Lang, J. C., Oda, Y., Kikuchi, H., Everson, M. P., Lotze, M. T. (1995) Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha. Cancer Gene Ther. 2, 113-124.
85. Ringenbach, L., Bohbot, A., Tiberghien, P., Oberling, F., Feugeas, O. (1998) Polyethylenimine-mediated transfection of human monocytes with the IFN-gamma gene: an approach for cancer adoptive immunotherapy. Gene Ther. 5, 1508-1516.
86. Wang, Q., Cao, X., Wang, J., Zhang, W., Tao, Q., Ye, T. (2000) Macrophage activation of lymphoma-bearing mice by liposome-mediated intraperitoneal IL-2 and IL-6 gene therapy. Chin. Med. J. 113, 281-285.
87. Richter, G., Kruger-Krasagakes, S., Hein, G., Huls, C., Schmitt, E., Diamantstein, T., Blankenstein, T. (1993) Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53, 4134-4137.
88. Kinne, R. W., Brauer, R., Stuhlmuller, B., Palombo-Kinne, E., Burmester, G. R. (2000) Macrophages in rheumatoid arthritis. Arthritis Res. 2, 189-202.
89. Fellowes, R., Etheridge, C. J., Coade, S., Cooper, R. G., Stewart, L., Miller, A. D., Woo, P. (2000) Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. Gene Ther. 7, 967-977.
90. Crowther, M., Brown, N. J., Bishop, E. T., Lewis, C. E. (2001) Macrophage regulation of angiogenesis in wound healing and malignant tumors: role of common microenvironmental stress factors? J. Leukoc. Biol 70, 478-490.
91. Meischl, C., Roos, D. (1998) The molecular basis of chronic granulomatous disease. Springer Semin. Immunopathol. 19, 417-434.
92. Poenaru, L. (2001) From gene transfer to gene therapy in lysosomal storage diseases affecting the central nervous system. Ann. Med. 33, 28-36.
93. Rojanasakul, Y., Weissman, D. N., Shi, X., Castranova, V., Ma, J. K., Liang, W. (1997) Antisense inhibition of silica-induced tumor necrosis factor in alveolar macrophages. J. Biol. Chem. 272, 3910-3914.
94. Hegyi, L., Hardwick, S. J., Slow, R. C., Skepper, J. N. (2001) Macrophage death and the role of apoptosis in human atherosclerosis. J. Hematother. Stem Cell Res. 10, 27-42.
95. Laukkanen, J., Lehtolainen, P., Gough, P. J., Greaves, D. R., Gordon, S., Yla-Herttuala, S. (2000) Adenovirus-mediated gene transfer of a secreted form of human macrophage scavenger receptor inhibits modified low-density lipoprotein degradation and foam-cell formation in macrophages. Circulation 101, 1091-1096.
96. Rekhter, M. D., Simari, R. D., Work, C. W., Nabel, G. J., Nabel, E. G., Gordon D. (1998) Gene transfer into normal and atherosclerotic human blood vessels. Circ. Res. 82, 1243-1252.
97. Inoue, S., Suzuki, M., Nagashima, Y., Suzuki, S., Hashiba, T., Tsuburai, T., Ikehara, K., Matsuse, T. Ishigatsubo, Y. (2001) Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum. Gene Ther. 12, 967-979.
98. Cremer, I., Vieillard, V., De Maeyer, E. (2000) Retrovirally mediated IFN-beta transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression. J. Immunol. 164, 1582-1587.
99. Wheeler, M. D., Yamashina, S., Froh, M., Rusyn, I., Thurman, R. G. (2001) Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production. J Leukoc. Biol. 69, 622-630.
100. Himes, S. R., Tagoh, H., Goonetilleke, N., Sasmono, T., Oceandy, D., Clark, R., Bonifer, C., Hume, D. A. (2001) A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression. J. Leukoc. Biol. 70, 812-820.
101. Greaves, D. R., Quinn, C. M., Seldin, M. F., Gordon, S. (1998) Functional comparison of the murine macrosialin and human CD68 promoters in macrophage and non-macrophage cell lines. Genomics 54, 165-168.
102. Kamimura, S., Tsukamoto, H. (1995) Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22, 1304-1309.
103. Mizuno, S., Izumi, T., Isaji, S. (2001) Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells. Dig. Dis. Sci. 46, 1299-1304.